Diagnostic Performance of 3T MRI T2 Mapping Technique in Chondro-labral Pathology of the Hip, Correlated With Intraoperative Arthroscopic Findings: Interventional Diagnostic Technique Validation Study (HPI MRI 3T)

Istituto Ortopedico Rizzoli

Overview

The goal of this observational study is to evaluate the diagnostic performance of the T2 mapping technique of the following 4 MRI scans in detecting hip chondro-labral lesions in comparison with intraoperative arthroscopic findings: 1) basal 3T MRI with T2 mapping technique, 2) 3T MRI with T2 mapping technique and limb traction; 3) 3T arthro-MRI with T2 mapping technique; 4) 3T arthro-MRI with T2 mapping technique and limb traction.

This study will evaluate the role of T2 mapping technique in the diagnosis of chondral and labral lesions of the hip. In particular, the following 4 types of MRI scan will be compared to each other and with intraoperative arthroscopic findings: * Basal 3T MRI without contrast * 3T MRI with limb traction * Arthro-RM 3T after intrarticular gadolinium and local anesthetic injection under ultrasound control * Arthro-RM 3T after intrarticular gadolinium and local anesthetic injection under ultrasound control + limb traction. The primary endpoint is to: * assess the diagnostic performance of baseline 3T MRI with T2 mapping technique in terms of sensitivity, specificity, PPV, and NPV in the diagnosis of hip labral lesions, according to Philippon's classification, and chondral lesions according to modified Outerbridge classification, * compare the diagnostic performance between all the mentioned above scans. The secondary endpoint is to evaluate the sensitivity, specificity, PPV and NPV of 3T MRI with longitudinal traction of the lower limb in detecting, localizing and grading chondral lesions of the coxo-femoral joint. The present study will involve 30 young patients with coxalgia non responding to conservative treatment and referable to a chondro-labrum injury based on clinical and imaging examinations. Patients will undergo RM diagnostic protocol and will receive hip arthroscopy within the next 6 months.

Study Type

OBSERVATIONAL

Conditions

Hip Injuries and Disorders Hip Arthrosis

Interventions

T2 mapping 3T MRI + hip arthroscopyDIAGNOSTIC_TEST

1. 3T MRI 2. hip arthroscopy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with symptomatic localized chondro-labral lesion requiring arthroscopic treatment * Consent to conduct the study * BMI\<30 Exclusion Criteria: * Patients unable to read or understand the patient information and consent forms; * Previous surgery on the same hip; * Coxarthrosis ≥ 2 according to Tonnis; * Acetabulum and/or proximal femur fractures; * Presence of psychological disorders, which might interfere with their ability to undergo the 4 MRI examinations; * Known sensitivity to gadolinium; * BMI ≥ 30; * Current infections; * Tumors; * Metabolic disorders; * Presence of peripheral neurological disorders such as pudendal neuralgia, peroneal neuralgia, neuralgia sciatica that traction may risk worsening.

Locations (1)

Istituto Ortopedico Rizzoli

Bologna, Italy

Outcomes

Primary Outcomes

T2 mapping 3T MRI

* Grade of cartilage lesions according to modified Outerbridge classification; * Grade of labrum lesions according to Philippon's classification; * Localization of cartilage lesions according to the clock system; * Localization of labrum lesions by the ROI (Region Of Interest) method.

Time frame: At baseline (Day 0)

Hip arthroscopy

Time frame: Within 6 months from day 0

Data comparison

In the postoperative phase, the intraoperative findings will be compared with the preoperative findings of the 4 MRI types by proceeding to calculate their sensitivity, specificity, PPV, NPV in relation to the degree and location of chondro-labral lesions of the hip.

Time frame: Within 21 months from beginning of the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.